Dec 13, 2016 14:30 pm UTC| Business
WOOD DALE, Ill., Dec. 13, 2016 -- Power Solutions International, Inc. (PSI) (NASDAQ:PSIX), a leader in the design, engineer and manufacture of emissions-certified, alternative-fuel power systems, presents its latest...
Eternity Healthcare Moves to Next Stage Regulatory Approval Phase with Lenis®
Dec 13, 2016 14:30 pm UTC| Business
PHOENIX and VANCOUVER, British Columbia, Dec. 13, 2016 -- Eternity Healthcare Inc. (OTC:ETAH), is pleased to announce completion of its Lenis®, Needle-Free Injection development phase. “This is a significant milestone...
WisdomTree U.S. Quality Dividend Growth Fund (DGRW) Surpasses $1 Billion in Assets
Dec 13, 2016 14:30 pm UTC| Business
NEW YORK, Dec. 13, 2016 -- WisdomTree (NASDAQ:WETF), an exchange-traded product (“ETP”) sponsor and asset manager, today announced the WisdomTree U.S. Quality Dividend Growth Fund (DGRW) recently surpassed $1 billion in...
Dec 13, 2016 14:29 pm UTC| Business
PLYMOUTH, Minn., Dec. 13, 2016 -- Entellus Medical, Inc. (NASDAQ:ENTL), a medical technology company focused on delivering superior patient and physician experiences through products designed for the minimally invasive...
Carnegie Technologies Adds Mobile Industry Veterans to Management Team
Dec 13, 2016 14:29 pm UTC| Business
SAN ANTONIO, Dec. 13, 2016 -- Carnegie Technologies, developers of the Network Convergence Platform for mobile network operators, wireline carriers, Internet service providers and smart car manufacturers, announced...
Actua Announces Final Results of Tender Offer
Dec 13, 2016 14:27 pm UTC| Business
RADNOR, Pa., Dec. 13, 2016 -- Actua Corporation(Nasdaq:ACTA) today announced the final results of its modified “Dutch auction” tender offer, which expired at 11:59 p.m., New York City time, on Wednesday, December 7,...
Intellia Therapeutics Names Graeme Bell Chief Financial Officer
Dec 13, 2016 14:20 pm UTC| Business
CAMBRIDGE, Mass., Dec. 13, 2016 -- Intellia Therapeutics, Inc. (NASDAQ:NTLA),a leading genome editing company focused on developing potentially curative therapeutics using CRISPR/Cas9 technology, has appointed Graeme...